We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Regulatory News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (Plethora Solutions Holdings plc)

17 Nov 2015 09:00

RNS Number : 9507F
Regent Pacific Group Limited
17 November 2015
 



FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Regent Pacific Group Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Plethora Solutions Holdings plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

16 November 2015

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES - Regent Pacific Group Limited

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

86,799,490

10.54

-

-

(2) Cash-settled derivatives:

 

-

-

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

-

-

-

-

 

TOTAL:

 

86,799,490

 

10.54

-

-

 

 

Class of relevant security:

 

Warrants 2019

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

12,649,745

12.50

-

-

(2) Cash-settled derivatives:

 

-

-

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

-

-

-

-

 

TOTAL:

 

12,649,745

 

12.50

-

-

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

-

Details, including nature of the rights concerned and relevant percentages:

-

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

The directors of Regent Pacific Group Limited and their concert parties have the following holdings in the securities of Plethora Solutions Holdings plc:

 

Director

Held in Own Name, or Concert Party

Number of 1p Ordinary Shares

Notes

James Mellon

Own Name

63,944,045 (7.77%)

(Registered holder is Vidacos Nominees

Limited)

Own Name

1,250,000 (0.15%)

Held by Jim Mellon Retirement Account.

(Registered holder is Pershing Nominees

Limited)

Concert Party:

Galloway Limited

 

82,414,726 (10.01%)

A company wholly owned by a settlement, of which James Mellon is a beneficiary.

(Registered holders are: Vidacos Nominees

Limited (69,414,726) and Pershing Nominees

Limited (13,000,000))

Concert Party:

ARBB AG (in liquidation)

1,600,000 (0.19%)

James Mellon is a 40.91 per cent. indirect shareholder.

(Registered holder is Lynchwood Nominees

Limited)

Concert Party:

Port Erin Biopharma Investments Limited

7,750,000 (0.94%)

James Mellon is a 29 per cent. shareholder and the chairman of Port Erin Biopharma Investments Limited.

(Registered holder is NY Nominees Limited)

Concert Party:

Gregory Bailey

555,600 (0.07%)

Held in own name.

TOTAL

157,514,371 (19.13%)

Director

Held in Own Name, or Concert Party

Number of 1p Ordinary Shares

Notes

Mark Searle

 

Own Name

300,000 (0.04%)

Held in own name.

Own Name

1,000,000 (0.12%)

Held by Mark Searle's Self Invested Personal Pension, of which Mark Searle is the sole beneficiary.

Own Name

400,000 (0.05%)

Held by Juliet Mary Druce Searle (Mark Searle's spouse).

TOTAL

1,700,000 (0.21%)

 

The directors of Regent Pacific Group Limited and their concert parties have the following rights to subscribe in the securities of Plethora Solutions Holdings plc:

 

Director

Held in Own Name, or Concert Party

Number of 1p Ordinary Shares

Notes

James Mellon

Own Name

1,000,000 (1.85%)

Entitlement under the Long Term Incentive Plan of Plethora Solutions Holdings plc, under which shares will be granted on a change of control of Plethora Solutions Holdings plc.

Concert Party:

Gregory Bailey

1,000,000 (1.85%)

Entitlement under the Long Term Incentive Plan of Plethora Solutions Holdings plc, under which shares will be granted on a change of control of Plethora Solutions Holdings plc.

TOTAL

2,000,000 (3.69%)

 

Director

Held in Own Name, or Concert Party

Number of 1p Ordinary Shares

Notes

Jamie Gibson

Own Name

35,000,000 (64.58%)

Entitlement under the Long Term Incentive Plan of Plethora Solutions Holdings plc, under which shares will be granted on a change of control of Plethora Solutions Holdings plc.

 

 

James Mellon, a director of Regent Pacific Group Limited, has the following relevant securities in Plethora Solutions Holdings plc:

 

Party

Number of Convertible Loan Notes 2020

Notes

James Mellon

17,000,000 (100.00%)

Convertible loan in the amount of £340,000, repayable on 31 March 2020, with an option to elect for this loan to be repaid in shares in Plethora Solutions Holdings plc at 2 pence.

 

Galloway Limited, a concert party of Regent Pacific Group Limited via James Mellon, has the following relevant securities in Plethora Solutions Holdings plc:

 

Party

Number of Galloway Warrants 2023

Notes

Galloway Limited

54,118,431 (100.00%)

Warrants to subscribe for 5 per cent. of the fully diluted share capital of Plethora Solutions Holdings plc, excisable at 1.25 pence on or before 31 March 2023. A company wholly owned by a settlement, of which James Mellon is a beneficiary.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

17 November 2015

Contact name:

Stella Fung

Telephone number:

+852 2514 6188

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEGIBDBIGBBGUR
Date   Source Headline
17th Nov 20107:00 amRNSChange of Adviser
10th Nov 20102:27 pmRNSHolding in Company
7th Sep 20107:00 amRNSHalf Yearly Report
29th Jul 20102:27 pmRNSHolding(s) in Company
23rd Jul 201010:55 amRNSHolding(s) in Company
19th Jul 20107:00 amRNSNew Product Launch
13th Jul 20107:00 amRNSPre-close Trading Update
30th Jun 20107:00 amRNSTerm Loan Agreement
10th Jun 201012:06 pmRNSLTIP Awards
2nd Jun 20107:00 amRNSAmerican Urological Association Showcase
27th May 20109:27 amRNSResult of AGM
17th May 20107:00 amRNSCommercial Update - The Urology Company
6th May 20107:00 amRNSAnnual Report and Accounts
5th May 20107:00 amRNSIssue of Equity
12th Apr 20107:00 amRNSExclusive Distribution Agreement
9th Mar 20107:00 amRNSPreliminary Results
24th Feb 20103:31 pmRNSHolding(s) in Company
23rd Feb 20107:00 amRNSNotice of Results
19th Jan 20107:00 amRNSPre-Close Trading Update
14th Dec 20095:23 pmRNSHolding(s) in Company
7th Dec 200911:23 amRNSResult of EGM
30th Nov 20097:00 amRNSExclusive License and Distribution Agreement
23rd Nov 20097:00 amRNSExclusive License and Distribution Agreement
19th Nov 20094:23 pmRNSDirector/PDMR Shareholding
18th Nov 20097:23 amRNSPlacing and Convertible Loan Note
30th Sep 20097:00 amRNSClinical Update re: PSD506
17th Sep 20097:00 amRNSInterim Results
7th Aug 20094:42 pmRNSHolding(s) in Company
5th Aug 200910:42 amRNSHolding(s) in Company
29th Jul 20097:00 amRNSFinal Phase III Pivotal Trial Results PSD502
16th Jul 20097:00 amRNSPSD503 Update - Evaluation and Option Agreement
25th Jun 20091:57 pmRNSAGM Statement and Trading Update
15th Jun 20093:57 pmRNSHolding(s) in Company
29th May 20093:34 pmRNSAnnual Report and Accounts and AGM Notice
26th May 20097:05 amRNSDirectorate Change
26th May 20097:00 amRNSGlobal Agreement, Restructuring and Final Results
1st Apr 20097:00 amRNSUpdate re: PSD502
19th Feb 20097:00 amRNSDirectorate Change
18th Feb 20099:24 amRNSClinical Update PSD502
16th Feb 200911:31 amRNSLoan Agreement and US License Amendment
16th Feb 200911:26 amRNSResult of General Meeting
22nd Jan 20097:00 amRNSFunding Update and Notice of GM
23rd Dec 20084:17 pmRNSHolding(s) in Company
18th Dec 200811:55 amRNSHolding(s) in Company
11th Dec 20089:12 amRNSHolding(s) in Company
8th Dec 20087:00 amRNSIssue of Equity
8th Dec 20087:00 amRNSClinical Update: PSD502
14th Nov 20087:00 amRNSHolding(s) in Company
14th Nov 20087:00 amRNSErecAid Study Results
7th Nov 20087:00 amRNSPhase III European Clinical Trial Results PSD502

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.